Ann Neurol
- KLUGE A, Borsche M, Streubel-Gallasch L, Gul T, et al
alpha-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a
Blood-Based Seed Amplification Assay.
Ann Neurol. 2024 Mar 28. doi: 10.1002/ana.26917.
Exp Brain Res
- FROUNI I, Kim E, Shaqfah J, Bedard D, et al
[(3)H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat
brain.
Exp Brain Res. 2024 Mar 25. doi: 10.1007/s00221-024-06815.
- MACDONALD HJ, Ruitenberg MFL
Dopamine system involvement in impulse control.
Exp Brain Res. 2024;242:781-782.
J Neural Transm (Vienna)
- HE G, Ren J, Shi H, Liu W, et al
Correlation between the MNCD classification-based staging of Parkinson's disease
and quality of life: a cross-sectional study.
J Neural Transm (Vienna). 2024 Mar 28. doi: 10.1007/s00702-024-02756.
J Neurochem
- NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
Infiltration of immune cells to the brain and its relation to the pathogenesis of
Alzheimer's and Parkinson's diseases.
J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
J Neurol Neurosurg Psychiatry
- KIM R, Choi S, Kang N, Park K, et al
Effects of high-intensity interval training and moderate-intensity continuous
training on non-motor symptoms in patients with Parkinson's disease: a randomised
pilot trial.
J Neurol Neurosurg Psychiatry. 2024 Mar 28:jnnp-2023-331990.
Mov Disord
- KAMATH SD, Holla VV, Phulpagar P, Kamble N, et al
Clinicogenetic Characterization of Patients with PD and Heterozygous GBA1
Variants in an Indian Cohort.
Mov Disord. 2024;39:628-630.
- MUNCHAU A, Klein C, Beste C
Rethinking Movement Disorders.
Mov Disord. 2024;39:472-484.
- THOMSEN M, Marth K, Loens S, Everding J, et al
Large-Scale Screening: Phenotypic and Mutational Spectrum in Isolated and
Combined Dystonia Genes.
Mov Disord. 2024;39:526-538.
- LEWITT PA, Stebbins GT, Christensen KV, Tan R, et al
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled,
Crossover Study.
Mov Disord. 2024;39:613-618.
- BINGHAM CS, McIntyre CC
Coupled Activation of the Hyperdirect and Cerebellothalamic Pathways with Zona
Incerta Deep Brain Stimulation.
Mov Disord. 2024;39:539-545.
- DING H, Nasseroleslami B, Mirzac D, Isaias IU, et al
Re-emergent Tremor in Parkinson's Disease: Evidence of Pathologic beta and
Prokinetic gamma Activity.
Mov Disord. 2024 Mar 26. doi: 10.1002/mds.29771.
- VERONESE N, Nova A, Fazia T, Riggi E, et al
Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson's
Disease.
Mov Disord. 2024 Mar 26. doi: 10.1002/mds.29778.
Neurobiol Dis
- IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
Investigation of microglial diversity in a LRRK2 G2019S mouse model of
Parkinson's disease.
Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
- JIAO LL, Dong HL, Liu MM, Wu PL, et al
The potential roles of salivary biomarkers in neurodegenerative diseases.
Neurobiol Dis. 2024;193:106442.
Neuroscience
- SALLY SAMSON J, Ramesh A, Deepa Parvathi V
Development of midbrain dopaminergic neurons and the advantage of using hiPSCs as
a model system to study Parkinson's disease.
Neuroscience. 2024 Mar 22:S0306-4522(24)00138.
Science
- NORMILE D
Transgenic marmosets mimic Parkinson's symptoms.
Science. 2024;383:1402.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016